Subscribe to Here’s the Deal, our politics
newsletter for analysis you won’t find anywhere else.
Thank you. Please check your inbox to confirm.
By Lauran Neergaard, Associated Press
Federal health advisers have narrowly backed an experimental vaccine from Pfizer that could become the first shot to protect older adults against the respiratory illness known as RSV.
By Matthew Perrone, Associated Press
For working parents of young children, it seems the rest of the world has moved on from the pandemic.
By Heather Hollingsworth, Claire Savage, Associated Press
The White House is warning of a surge of illness this holiday season, as the country deals with the simultaneous uptick of three, highly contagious respiratory viruses. Hospitals across the country are filling up with patients suffering from flu, RSV…
By William Brangham, Courtney Norris
The Biden administration is once more making some free COVID-19 tests available to all U.S. households as it releases its contingency plans with coronavirus cases ticking upward this winter.
By Zeke Miller, Associated Press
By Liz Szabo, Kaiser Health News
The dire shortage of pediatric hospital beds is a byproduct of financial decisions made by hospitals over the past decade, as they shuttered children’s wards, which often operate in the red, and expanded the number of beds available for more…
By Associated Press
The European Commission has authorized the world's first one-dose drug against a respiratory virus that sickens millions of babies and children globally every year.
The preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be getting close.
By Carla K. Johnson, Associated Press
People infected are usually contagious for three to eight days. Babies and people with weakened immune systems can spread RSV for up to four weeks. There is no vaccine for it, though several candidates are in testing.
Support Provided By: